News
More Evidence Avatar Therapy Quiets Auditory Hallucinations in Psychosis
The therapy allows patients to interact with a “digital embodiment” of the voice they hear, which is represented by a computer-generated face,...
News
Hearing Loss, Hearing Aids, and Dementia Risk: What to Tell Your Patients
While quantifying the exact increase in risk is challenging, “there’s no doubt about it; it’s not trivial.”
News
Electroconvulsive Therapy Works, Now Scientists Believe They Know How
ECT is primarily used for treatment-resistant depression and is effective in up to 80% of patients, yet it remains one of the least prescribed...
News
Buprenorphine may curb opioid-induced respiratory depression
“I think this is an approach that works, and this study makes that clear,” said Dr. Geert Jan Groeneveld.
News
FDA OKs stimulation device for anxiety in depression
The neurostimulation system has previously received FDA approval for refractory depression, obsessive-compulsive disorder, and smoking addiction...
News
Pfizer recalls four more lots of smoking cessation drug Chantix
On July 2, the FDA reported that Pfizer had voluntarily recalled nine lots of the drug.
News
FDA head calls for investigation into agency’s approval of aducanumab (Aduhelm)
An independent investigation will examine whether anything occurred that was “inconsistent with FDA policies and procedures.”
News
FDA leader explains rationale leading to controversial Alzheimer’s drug approval
In view of the “fierce public debate” that erupted immediately following the drug’s approval, the FDA felt compelled to explain how it reached its...
News
FDA approves controversial Alzheimer’s drug aducanumab (Aduhelm)
Approval was granted despite an FDA advisory panel recommendation not to approve the drug.
News
Once-nightly sodium oxybate agent effective in narcolepsy
All three doses of the novel agent were associated with significant improvements in sleep quality, refreshing nature of sleep, sleep paralysis,...
News
COVID-19 linked to novel epileptic seizures
Among patients with new-onset seizures, hospital stays were about 15 days longer – and mortality rates were significantly higher.
News
Common MS treatment wears off more quickly in Black patients
These findings may have implications for the way Black patients with autoimmune diseases are treated in the future.
News
Simple blood test plus AI may flag early-stage Alzheimer’s disease
Deep Learning’s assessment of intragenic cytosine-phosphate-guanines (CpGs) had sensitivity and specificity rates of 97%.